Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1056 participants.

Also called NCT03242642

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,056 participants (planned count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03242642
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03242642. Non-randomized; no masking; primary purpose treatment. Start 2017-10-23 (actual); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Acronym
APOLLO
Condition
Mitral Valve Regurgitation
Intervention (Device)
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Intervention (Device)
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct03242642
Content hash
d012d623ba10b683ae7dc657b2e1892dfcd225b8f7651ebf6d1b0f378e4590d1